Decreased hypothalamic serotonin levels in adult rats treated neonatally with clomipramine

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 4, 1996, Pages 647-652

  Feenstra, Matthijs G P ^a   Van Galen, Hugo ^a   Te Riele, Paula J M ^a   Botterblom, Margriet H A ^a   Mirmiran, Majid ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

adrenergic receptors; antidepressant drugs; brain development; clomipramine; depression; dopamine metabolism; hypothalamus; serotonin

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CLOMIPRAMINE; DIHYDROXYPHENYLACETIC ACID; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; FEMALE; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANIMALS, NEWBORN; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BIOGENIC MONOAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOMIPRAMINE; DEPRESSION, CHEMICAL; DOPAMINE; FEMALE; HYPOTHALAMUS; MALE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; SEROTONIN;

EID: 0030447703     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00276-6     Document Type: Article

References (30)

1. 3H]RX821002, Biog Amines, 9 (1993) 259-269.
2. 3H]norepinephrine in the rat brain, J. Neurochemistry, 18 (1971) 2061-2075.
3. 3. De Boer, S., Mirmiran, M., Van Haaren, F., Louwerse, A. and Van de Poll, N.E., Neurobehavioral teratogenic effects of clomipramine and alpha-methyldopa. Neurotoxicol. Teratol., 11 (1989) 77-84.
4. 4. Del Río, J., Montero, D., De Ceballos, M.L., Long-lasting changes after perinatal exposure to antidepressants. In: G.J. Boer, M.G.P. Feenstra, M. Mirmiran, D.F. Swaab and F. Van Haaren (Eds.), Biochemical basis of functional neuroteratology. Permanent effects of chemicals on the developing brain, Progress in Brain Research, Vol. 73, Elsevier, Amsterdam, 1988, pp 173-187.
5. 3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression, J. Neurochem., 56 (1991) 1581-1586.
6. 6. Erdtsieck-Ernste, E.B.H.W., Feenstra, M.G.P, and Boer, G.J., Pre- and postnatal developmental changes of adrenoceptor subtypes in rat brain, J. Neurochem., 57 (1991) 897-903.
7. 7. Erdtsieck-Ernste, E.B.H.W., Feenstra, M.G.P. and Boer, G.J., Perinatal influence of β-adrenergic drugs on the noradrenergic system of the rat brain, Gen. Pharmacol., 24 (1993) 1069-1078.
8. 8. Feenstra, M.G.P., Snijdewint, F.G.M., Van Galen, H. and Boer, G.J., Widespread alterations in central noradrenaline, dopamine, and serotonin systems in the Brattleboro rat not related to the local absence of vasopressin, Neurochem. Res., 15 (1990) 283-288.
9. 9. File, S.E. and Tucker, J.C., Neonatal clomipramine treatment in the rat does not affect social, sexual and exploratory behaviors in adulthood, Neurobehav. Toxicol. Teratol. 5 (1983) 3-8.
10. 10. Grimm, V.E. and Frieder, B., Prenatal and early postnatal exposure to zimelidine: behavioral, neurochemical and histological findings in rats, Int. J. Neurosci., 33 (1987) 225-235.
11. 11. Heninger, G.R. and Charney, D.S., Mechanism of action of antidepressant treatments: implications for the etiology and treatment of depressive disorders, In H. Y. Meltzer (Ed.) Psychopharmacology: The third generation of progress, Raven Press, New York, 1987 pp 535-544.
12. 12. Hilakivi, L.A. and Hilakivi, I., Increased adult behavioral despair in rats neonatally exposed to desipramine or zimeldine: an animal model of depression?, Pharmacol. Biochem. Behav., 28 (1987) 367-369.
13. 13. Hilakivi, L.A., Hilakivi, I., Ahtee, L., Haikala, H. and Attila, M., Effect of neonatal nomifensine exposure on adult behavior and brain monoamines in rats, J. Neural Transm., 70 (1987) 99-116.
14. 14. Hilakivi, L.A., Stenberg, D., Sinclair, J.D. and Kilanmaa, K., Neonatal desipramine or zimeldine treatment causes long-lasting changes in brain monoaminergic systems and alcohol related behavior in rats, Psychopharmacol., 91 (1987) 403-409.
15. 15. Hilakivi, L.A., Taira, T., Hilakivi, I. and Loikas, P., Neonatal treatment with monoamineuptake inhibitors alters later response in behavioural 'despair' test to β and GABA-B receptor agonists, Pharmacol. Toxicol., 63 (1988) 57-61.
16. 16. Hyttel, J., Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 6 (1982) 277-295.
17. 17. Karki, N., Kuntzman, R. and Brodie, B.B., Storage, synthesis and metabolism of monoamines in the developing brain, J. Neurochemistry, 9 (1962) 53-58.
18. 18. Maudhuit, C., Hamon, M. and Adrien, J., Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression, NeuroReport 6 (1995) 681-684.
19. 19. McPherson, G.A., Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC, J. Pharmacol. Methods, 14 (1985) 213-228.
20. 20. Mirmiran, M., Van de Poll, N.E., Corner, M.A., Van Oyen, H.G. and Bour, H.L., Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat, Brain Res., 204 (1981) 129-146.
21. 21. Mirmiran, M., Scholtens, J., Van de Poll, N.E., Uylings, H.B.M., Van der Gugten, J. and Boer, G.J., Effects of experimental suppression of active (REM) sleep during early development upon adult brain and behavior in the rat, Devel. Brain Res., 7 (1983) 277-286.
22. 22. Ogawa, T., Mikuni, M., Kuroda, Y., Muneoka, K., Mori, K.J. and Takahashi, K., Effects of the altered serotonergic signalling by neonatal treatment with 5,7-dihydroxytryptamine, ritanserin or clomipramine on the adrenocortical stress response and the glucocorticoid receptor binding in the hippocampus in adult rats, J. Neural Transm. 96 (1994) 113-123.
23. 23. Racagni, G., Mocchetti, I., Brunello, N., Renna, G. and Cuomo, V., Early biochemical and behavioral changes after prolonged exposure to antidepressant drugs. In G. Zbinden, V. Cuomo, G. Racagni, B. Weiss (Eds.) Application of behavioral pharmacology in toxicology, Raven Press, New York, 1983, pp 161-171.
24. 24. Rosenwasser, A.M. and Hayes, M.J., Neonatal desipramine treatment alters free-running circadian drinking rhythms in rats, Psychopharmacol. 115 (1994) 237-244.
25. 25. Ugrumov, M.V., Proshlyakova, E.V. and Sapronova, A., Development of the hypothalamic 5-hydroxytryptamine system during ontogenesis in rats: uptake and release of 5-hydroxytryptamine in vitro, Neuroscience, 32 (1989) 127-131.
26. 26. Velazquez-Moctezuma, J. and Diaz Ruiz, O., Neonatal treatment with clomipramine increased immobility in the forced swim test: an attribute of animal models of depression, Pharmacol. Biochem. Behav., 42 (1992) 737-739.
27. 27. Velazquez-Moctezuma, J., Aguilar-Garcia, A. and Diaz-Ruiz, O., Behavioral effects of neonatal treatment with clomipramine, scopolamine, and idazoxan in male rats. Pharmacol. Biochem. Behav., 46 (1993) 215-217.
28. 28. Vogel, G., Neill, D., Hagler, M. and Kors, D., A new animal model of endogenous depression: a summary of present findings. Neurosci. Biobehav. Rev., 14 (1990) 85-91.
29. 29. Westerink, B.H.C., Analysis of trace amounts of catecholamines and related compounds in brain tissue: a study near the detection limit of liquid chromatography with electrochemical detection, J. Liq. Chromatogr., 6 (1983) 2337-2351.
30. 30. Yavari, P., Vogel, G.W. and Neill, D.B., Decreased raphe unit activity in a rat model of endogenous depression, Brain Res., 611 (1993) 31-36.